Sources and Actions of Gm-Csf and Multi-Csf

Sieff, Colin A.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA045559-08
• Application #: 2091922
• Study Section: Hematology Subcommittee 2 (HEM)
• Project Start: 1987-09-01
• Project End: 1997-02-28
• Budget Start: 1995-03-01
• Budget End: 1997-02-28
• Support Year: 8
• Fiscal Year: 1995

Institution

• Name: Dana-Farber Cancer Institute
• DUNS #: 149617367
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02215

Publications

Jubinsky, P T; Krijanovski, O I; Nathan, D G et al. (1997) The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood 90:1867-73

Shikama, Y; Barber, D L; D'Andrea, A D et al. (1996) A constitutively activated chimeric cytokine receptor confers factor-independent growth in hematopoietic cell lines. Blood 88:455-64

Jubinsky, P T; Shikama, Y; Laurie, A et al. (1996) The beta c component of the granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin 3 (IL-3)/IL-5 receptor interacts with a hybrid GM-CSF/erythropoietin receptor to influence proliferation and beta-globin mRNA expression. Mol Med 2:766-73

Nathan, D G (1994) Studies of hybrid hematopoietic growth factor receptors. Stem Cells 12 Suppl 1:27-33;discussion 33-5